Abalone Bio develops target-activating antibodies using its Functional Antibody Selection Technology (FAST) platform, which enables the rapid identification of antibody activators for challenging G-protein coupled receptors (GPCRs). This approach addresses the lack of effective therapeutics for key disease targets, providing a solution to the specificity issues associated with existing small molecule drugs.

Aether is a strategic marketing platform that transforms static data into actionable knowledge by creating a searchable repository of insights. It automates the generation of on-brand decks, summaries, and reports, ensuring consistent messaging and efficient activation of institutional knowledge across marketing, insights, sales, and communications teams.

Auransa has developed a proprietary AI platform that analyzes extensive human disease data to identify novel therapeutics tailored for specific patient populations. The platform addresses the challenge of understanding complex diseases by predicting molecular disease subtypes and potential treatment responses based on genomic insights.

Babylon Micro-Farms provides a semi-automated indoor farming system that utilizes hydroponics to enable year-round cultivation of fresh produce in various environments. This technology addresses the challenges of food sustainability and accessibility by allowing users to grow nutritious crops on-site, reducing reliance on transportation and enhancing community engagement.

Bit.bio develops a cell coding platform that utilizes deterministic programming to create and manufacture any human cell type with precision and scalability. This technology addresses the need for consistent and reliable cell production for research and therapeutic applications, enabling the development of next-generation treatments.

Caresyntax provides an AI-powered, vendor-neutral surgical intelligence platform that integrates data from electronic medical records, video, and device metrics to enhance surgical workflow and decision-making. The platform improves patient outcomes, operational efficiency, and profitability by offering real-time support during procedures and comprehensive analytics for pre- and post-operative care.

DermaSensor provides an FDA Cleared, handheld device that uses optical spectroscopy and proprietary AI algorithms to non-invasively assess suspicious skin lesions. This technology delivers instant risk assessment outputs to aid healthcare providers in making objective referral decisions for melanoma, basal cell carcinoma, and squamous cell carcinoma. The system enhances clinical confidence by offering rapid, objective data to supplement traditional visual assessment at the point of care.

GEn1E is a clinical-stage company utilizing a multi-target AI platform to develop first-in-class immunomodulators that specifically target kinase dysregulation in rare inflammatory diseases. Their approach employs novel allosteric binding mechanisms to enhance therapeutic specificity while minimizing off-target effects and toxicity associated with traditional kinase inhibitors.

Halo Industries develops proprietary laser-based hardware for silicon carbide (SiC) wafering, achieving superior wafer-per-millimeter yield while minimizing material stress and kerf loss. The technology enhances manufacturing efficiency by reducing material, energy, and water consumption compared to traditional wafering methods.

Insilico Medicine utilizes a generative AI platform to streamline drug discovery and development for cancer and age-related diseases, significantly reducing the time and cost associated with bringing new medications to market. The platform integrates multi-omics data analysis and machine learning to identify novel drug targets and predict clinical trial outcomes, enhancing the efficiency of pharmaceutical research.

Juvena Therapeutics utilizes an AI-driven platform to identify and engineer secreted proteins into biologic therapeutics that restore tissue homeostasis. The company addresses the dysregulation of protein signaling that leads to degenerative diseases, including myopathies and metabolic disorders.

Loft Orbital provides satellite leasing services that enable organizations to deploy payloads for Earth observation and data collection. By integrating, testing, and operating satellite missions, Loft Orbital allows clients to access timely and relevant information from space without the complexities of satellite ownership and operation.

Provides a shared progress tracking platform for coaches and clients, enabling clients to log actions, track goals, and maintain accountability between sessions. Coaches gain measurable insights into client progress and engagement through customizable logs, reminders, and real-time feedback tools, improving the effectiveness of their practice.

Nelumbo develops metamaterials with precise surface structures to enhance the energy efficiency and performance of heating and cooling systems, addressing the significant carbon emissions associated with traditional materials production. Their technology mitigates issues like frost and ice formation, enabling more effective and sustainable climate control solutions.

Paradromics is developing a high data-rate brain-computer interface (BCI) that directly accesses individual neural signals to enable communication for individuals with severe motor impairments. The Connexus Direct Data Interface translates neural activity into synthesized speech and cursor control, facilitating social connection and restoring independence for users.

Pragma Bio utilizes an AI-enabled, biology-first platform to discover novel small molecules targeting the gut-immune axis for therapeutic development. The platform, PIKASO, mines clinically-relevant Biosynthetic Gene Clusters (BGCs) using multi-omics data to identify de-risked starting points for new medicines. This approach leverages naturally evolved molecules to uncover disease-modifying pathways and accelerate small molecule drug discovery.

RAD AI utilizes machine learning algorithms to analyze real-time conversations from social media platforms, generating actionable audience insights within 24 hours. This technology enables brands to effectively target specific demographics with tailored messaging, enhancing engagement and campaign performance.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

Science is a clinical-stage technology company developing biohybrid neural interfaces and advanced neural recording electronics to address serious unmet medical needs in neuroscience. Their technologies aim to enhance neural communication and restore vision, facilitating new treatment possibilities for patients with neurological disorders.

Sorcero's Language Intelligence Platform utilizes medically-tuned AI to unify and analyze structured and unstructured medical data, enabling teams to extract actionable insights for informed decision-making. The platform addresses the challenge of rapidly identifying relevant safety signals and optimizing treatment strategies, significantly enhancing productivity and accuracy in medical affairs and regulatory processes.

Strateos offers a robotic cloud lab automation platform that enables scientists to remotely design, execute, and analyze high-throughput experiments in drug discovery and synthetic biology. This technology addresses the inefficiencies of traditional laboratory workflows by providing scalable access to automated lab capabilities, significantly reducing hands-on time and increasing productivity.

Trana provides a platform for developing digital training courses tailored for corporate clients, partners, and employees. The software streamlines course creation and management, enhancing employee skill development and compliance training efficiency.

Unlimited Tomorrow provides high-quality, low-cost myoelectric prosthetic arms, specifically the TrueLimb, which features a lightweight design and a socket lined with over 30 sensors for intuitive control. This technology addresses the lack of accessible and affordable bionic solutions for individuals with upper limb differences, enhancing their daily functionality and independence.

Vi provides a digital platform offering personalized support and expert guidance for women navigating perimenopause and menopause symptoms. The platform delivers tailored content, symptom tracking, and access to certified menopause professionals for individual consultation. This service helps organizations support female employees, aiming to reduce absence and maintain team performance during this life stage.